The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Levitt Daniel J since 2012.
The trader's CIK number is 1278711.
At the time of the last reporting, Levitt Daniel J was the Chief Medical Officer of Neoleukin Therapeutics, Inc.. (stock ticker symbol NLTX).
Also see all insider trading activities at Neoleukin Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | AQXP | 0 | $0 | 3,906 | $49,489 | 3,906 | $41,247 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | CYTR | 100,000 | $28,699 | 0 | $0 | 0 | $0 |
1. Neoleukin Therapeutics, Inc. (AQXP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-14 | AQXP | Sale | 3,906 | 12.67 | 49,489 |
| 2018-05-14 | AQXP | Option Ex | 3,906 | 10.56 | 41,247 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-02-22 | CYTR | Buy | 100,000 | .29 | 28,699 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levitt Daniel J (Chief Medical Officer of Neoleukin Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.